| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |